Related Experiment Video
Updated: Dec 19, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
PD-1: Its Discovery, Involvement in Cancer Immunotherapy, and Beyond
1Division of Biological Science, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma-shi, Nara 630-0192, Japan.
Insights
The programmed death-1 (PD-1) molecule, crucial in immune research, has a long history. Further research is needed to fully understand PD-1's role in the immune system's self-nonself discrimination.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- The programmed death-1 (PD-1) molecule was first isolated in the early 1990s.
- The significance of PD-1 in biological research was recognized with the 2018 Nobel Prize in Physiology or Medicine.
- Despite advancements, the full implications of PD-1 research are still being explored.
Purpose of the Study:
- To review the historical journey of programmed death-1 (PD-1) research.
- To discuss the ongoing research and future directions in the field of PD-1.
- To highlight the potential roles of PD-1 in immune system's self-nonself discrimination.
Main Methods:
- Literature review of programmed death-1 (PD-1) research.
- Analysis of PD-1's function in immunological self-nonself discrimination.
- Discussion of historical context and future perspectives in PD-1 research.
Main Results:
- The isolation of the PD-1 molecule in the early 1990s marked a significant milestone.
- The 2018 Nobel Prize underscored the importance of PD-1 research.
- PD-1 plays a critical role in the immune system's ability to distinguish self from non-self.
Conclusions:
- The journey of programmed death-1 (PD-1) research is extensive, with significant milestones achieved.
- Further investigation is essential to fully elucidate the complex functions of PD-1.
- Understanding PD-1's role in self-nonself discrimination is crucial for advancing immunology and medicine.
Abstract:
On December 10, 2018, I was sitting among the big crowd of audience, as one of the invited guests to the ceremony, in the Stockholm Concert Hall. When King of Sweden Carl XVI Gustaf bestowed the diploma and medal of Nobel Prize of Physiology or Medicine 2018 on Dr. Tasuku Honjo and shook his hand for a while, surrounded by the thunderous applause and energetically blessing orchestral music, I thought that it had been a long journey for the molecule that we had first isolated in the early 1990s. Although it was truly a commemorable moment in the history of the programmed death-1 (PD-1) research, I believe we still have a long way to go. In this review article, I will explain why I think so, particularly by focusing on the potential role(s) that PD-1 appears to play in self-nonself discrimination by the immune system.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

